Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Some people may experience stomach upset with higher doses
During the screening process, 32 patients were excluded because of severe comorbidities,25 patients with history of malignancy were excluded and another 30 were excluded due to incomplete follow-up data
On the opportunity front, emerging markets with large diabetic populations, increasing acceptance of biosimilars in developed countries, advancements in biomanufacturing technologies, and the potential for new indications beyond diabetes and obesity (such as cardiovascular and neurodegenerative diseases) present significant growth potential
Educational content
US$ 21.32
US$ 24.41
US$ 23.00
US$ 22.49
US$ 29.26
